Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Correction

Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

Authors: Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, Florin A. Caruntu, Won Young Tak, Magdy Elkhashab, Wan-Long Chuang, Fehmi Tabak, Rajiv Mehta, Jörg Petersen, William Guyer, Belinda Jump, Alain Chan, Mani Subramanian, Gerald Crans, Scott Fung, Maria Buti, Giovanni B. Gaeta, Aric J. Hui, George Papatheodoridis, Robert Flisiak, Henry L. Y. Chan

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Excerpt

The original version of this article unfortunately contained affiliation and textual errors. This has been corrected with this erratum. …
Metadata
Title
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Authors
Sang Hoon Ahn
Patrick Marcellin
Xiaoli Ma
Florin A. Caruntu
Won Young Tak
Magdy Elkhashab
Wan-Long Chuang
Fehmi Tabak
Rajiv Mehta
Jörg Petersen
William Guyer
Belinda Jump
Alain Chan
Mani Subramanian
Gerald Crans
Scott Fung
Maria Buti
Giovanni B. Gaeta
Aric J. Hui
George Papatheodoridis
Robert Flisiak
Henry L. Y. Chan
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5294-y

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue

Multicenter Seminars: IBD (MUSE: IBD)

Introduction to the IBD Case Conference Series

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine